90 related articles for article (PubMed ID: 28668842)
1. Diagnostic Value of Systemic Cholesteryl Ester/Free Cholesterol Ratio in Hepatocellular Carcinoma.
Krautbauer S; Weiss TS; Wiest R; Schacherer D; Liebisch G; Buechler C
Anticancer Res; 2017 Jul; 37(7):3527-3535. PubMed ID: 28668842
[TBL] [Abstract][Full Text] [Related]
2. Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma.
Krautbauer S; Meier EM; Rein-Fischboeck L; Pohl R; Weiss TS; Sigruener A; Aslanidis C; Liebisch G; Buechler C
Biochim Biophys Acta; 2016 Nov; 1861(11):1767-1774. PubMed ID: 27570113
[TBL] [Abstract][Full Text] [Related]
3. Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma.
Haberl EM; Weiss TS; Peschel G; Weigand K; Köhler N; Pauling JK; Wenzel JJ; Höring M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069902
[TBL] [Abstract][Full Text] [Related]
4. Associations of systemic sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol.
Krautbauer S; Wiest R; Liebisch G; Buechler C
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():25-32. PubMed ID: 28647317
[TBL] [Abstract][Full Text] [Related]
5. Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma.
Buechler C; Aslanidis C
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158658. PubMed ID: 32058031
[TBL] [Abstract][Full Text] [Related]
6. Hepatocarcinogenesis and ceramide/cholesterol metabolism.
Morales A; Mari M; Garcia-Ruiz C; Colell A; Fernandez-Checa JC
Anticancer Agents Med Chem; 2012 May; 12(4):364-75. PubMed ID: 22043999
[TBL] [Abstract][Full Text] [Related]
7. Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS.
Chen S; Yin P; Zhao X; Xing W; Hu C; Zhou L; Xu G
Electrophoresis; 2013 Oct; 34(19):2848-56. PubMed ID: 24228263
[TBL] [Abstract][Full Text] [Related]
8. Abnormal lipid and lipoprotein patterns in liver cirrhosis with and without hepatocellular carcinoma.
Ahaneku JE; Taylor GO; Olubuyide IO; Agbedana EO
J Pak Med Assoc; 1992 Nov; 42(11):260-3. PubMed ID: 1336073
[TBL] [Abstract][Full Text] [Related]
9. Serum lipids in hepatoma.
Alsabti EA
Oncology; 1979; 36(1):11-4. PubMed ID: 221872
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice.
Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2021 Oct; 20(1):135. PubMed ID: 34629057
[TBL] [Abstract][Full Text] [Related]
11. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
Platelets; 2015; 26(6):577-82. PubMed ID: 25275728
[TBL] [Abstract][Full Text] [Related]
12. Cholesteryl ester metabolism in tissue culture cells: II. Source of accumulated esterified cholesterol in Fu5AH rat hepatoma cells.
Rothblat GH; Arbogast L; Kritchevsky D; Naftulin M
Lipids; 1976 Feb; 11(2):97-108. PubMed ID: 175234
[TBL] [Abstract][Full Text] [Related]
13. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
Grammatikos G; Schoell N; Ferreirós N; Bon D; Herrmann E; Farnik H; Köberle V; Piiper A; Zeuzem S; Kronenberger B; Waidmann O; Pfeilschifter J
Oncotarget; 2016 Apr; 7(14):18095-105. PubMed ID: 26933996
[TBL] [Abstract][Full Text] [Related]
14. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R
J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
[TBL] [Abstract][Full Text] [Related]
15. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
16. Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.
Wang W; Zhao LJ; Wang Y; Tao QY; Feitelson MA; Zhao P; Ren H; Qi ZT
Cancer Biomark; 2011-2012; 11(1):29-39. PubMed ID: 22820138
[TBL] [Abstract][Full Text] [Related]
17. [Expression of p21 in hepatocellular carcinoma and liver cirrhosis and its relation with HBV infection].
Ren CS
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):88-90. PubMed ID: 1655296
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma.
El-Mir MY; Badia MD; Luengo N; Monte MJ; Marin JJ
Clin Sci (Lond); 2001 May; 100(5):499-508. PubMed ID: 11294690
[TBL] [Abstract][Full Text] [Related]
19. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P
Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642
[TBL] [Abstract][Full Text] [Related]
20. Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis.
Inagaki Y; Xu HL; Hasegawa K; Aoki T; Beck Y; Sugawara Y; Tang W; Kokudo N
J Dig Dis; 2011 Dec; 12(6):481-8. PubMed ID: 22118699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
